Taken together, these results demonstrated that PVT1 induced gemcitabine resistance is associated with increased Wnt/β-catenin signaling and autophagic activity, and inhibition of Wnt/β-catenin signaling or autophagy increased the sensitivity of human pancreatic cancer cells to gemcitabine. This evidence concerns the gene PVT1 and familial pancreatic carcinoma.